Baum, Hedlund, Aristei & Goldman Files Lawsuits Against Avandia Manufacturer

Our pharmaceutical drug litigation team has filed Avandia lawsuits against GlaxoSmithKline (GSK) alleging that GSK negligently and carelessly failed to fully disclose to physicians, patients,and regulatory authorities the results of testing and other information in its possession from its clinical trials that showed an association between Avandia and heart failure, heart attacks, myocardial ischemia and ischemic events such as cardiovascular mortality, myocardial infarction and stroke.

Baum, Hedlund, Aristei & Goldman's drug product injury litigation team  is representing many individuals who were taking Avandia and suffered a heart attack or coronary artery blockage that required a stent or bypass surgery.  The firm is also representing individuals who suffered from a stroke or congestive heart failure while taking the drug.  Our firm has represented thousands of victims of pharmaceutical drug-induced injuries and death for more than 25 years.

Nurse’s Family Files Avandia Wrongful Death Lawsuit against GlaxoSmithKline

Rogelio Larosa and his adult son, Eric, of National City, San Diego County, California, filed a lawsuit on Monday, December 17, 2007, against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Avandia (rosiglitazone maleate), accusing GSK of causing the wrongful death of a Chula Vista nurse due to its negligence, fraud, breach of warranty and a failure to warn about the risks of its drug, Avandia.

The lawsuit alleges that Milagros Larosa, 65, over the course of one year, was hospitalized three different times for heart problems, and ultimately suffered a fatal stroke, caused by the Avandia she was taking for her type 2 diabetes. She had no prior heart problems or any type of a heart condition before starting Avandia. Read More